DrugDashboards

Market view

conjugated estrogens · Injection, Powder, Lyophilized, For Solution

1 marketed package NDCs · 1 active manufacturer

Most dispensed: ESTROGENS, CONJUGATED .625 mg/g · Cream · #1 tube, with applicator/carton / 30 g in 1 tube, with applicator

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for conjugated estrogens, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Premarin VaginalAug 19, 2026
    Price up
    NADAC $15.07945 → $15.08385 per unit (+0.03%)
  • Premarin VaginalJul 22, 2026
    Price down
    NADAC $15.08277 → $15.07945 per unit (-0.02%)

Same drug class

Other molecules FDA puts in Estrogen, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Conjugated estrogens in shortage right now?
No. FDA does not currently list Conjugated estrogens in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Conjugated estrogens?
3 companies have marketed Conjugated estrogens in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
What does Conjugated estrogens cost?
The typical pharmacy pays about $15.08 per gram, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.